Sept 21 (Reuters) – Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
South Korea to brief lawmakers on US investment package amid profitability concerns
By Joyce Lee SEOUL, Sept 22 (Reuters) - South Korea's government is due to brief…
Alcaraz, Zverev and Noah arrive ahead of Laver Cup in London
VIDEO SHOWS: TENNIS PLAYERS REPRESENTING TEAM EUROPE IN THE LAVER CUP, CARLOS ALCARAZ, ARRIVING AND…
Sep 22 (OPTA) - Final Rounds and Seeds Progress from the WTA 500, Singapore Tennis…
